C EGFR T790M gene variant face roughly 25 times the lung cancer risk of noncarriers, according to the largest-yet study of ...

Allon Klein, professor of systems biology in the Blavatnik Institute at Harvard Medical School, has been named a 2026 Schmidt ...

In a clinical trial, the drug, daraxonrasib, doubled survival time for patients with previously treated metastatic pancreatic ...

Daley laid out the institution’s response to recent challenges from the federal government and described a path forward that ...

Commitment to leadership in nutrition education began in 1942 and continues to evolve with requirements and electives for students, trainees, professionals, and the public.

Approach builds on prime editing, advances journey toward universal gene therapies ...

Study provides insights into the molecular changes that drive hypertrophic cardiomyopathy (HCM), a thickening and stiffening of heart muscle that can lead to heart failure or sudden cardiac arrest.

Study suggests CDK2 inhibitors, currently being tested to slow cell growth in a few types of cancer, could be used to reduce resistance to immunotherapy across a wider range of cancers. Work ...

A $46 million grant from a new autism research initiative, Aligning Research to Impact Autism (ARIA), is turbocharging efforts at Harvard and Yale to understand human brain development and provide ...

In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, became the recipient of a donated human kidney. His case represents the longest dialysis-free survival ...

Made possible through the generous support of Bristol Myers Squibb, the BMS Collaborative Research Fellowship will fund select Harvard Medical School postdoctoral fellows to pursue their boldest ...